SCHEMBL4111382

SCHEMBL4111382

CC(C)OC(=O)CC1SC(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
ALOX15 P16050 2/20 0.49
TSHR P16473 2/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CASP1 P29466 1/20 0.49
CYP2C19 P33261 1/20 0.49
RECQL P46063 1/20 0.49
SLC8B1 Q6J4K2 1/20 0.49
CDYL2 Q8N8U2 1/20 0.41
CDYL Q9Y232 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 2/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
PYGL P06737 1/20 0.37
PYGM P11217 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4111380 1.00 MAPT (0.49) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4111383 1.00 MAPT (0.49) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4125210 0.90 MAPT (0.45) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4125217 0.90 MAPT (0.45) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4125214 0.90 MAPT (0.45) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4129633 0.89 CDYL2 (0.43) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4129636 0.89 CDYL2 (0.43) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4129644 0.89 CDYL2 (0.43) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4112080 0.89 CDYL2 (0.41) MAPTALOX15TSHRTP53CYP1A2
SCHEMBL4112084 0.89 CDYL2 (0.41) MAPTALOX15TSHRTP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR MAPT 4428/4885ALOX15 302/4885TSHR 1672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.